Nuclear Medicine and Biology

Article	Citations
Review on 99mTc radiopharmaceuticals with emphasis on new advancements	92
Potent candidates for Targeted Auger Therapy: Production and radiochemical considerations	57
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy: A review of the lessons learnt so far	55
On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion	49
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historica	47
Production, purification and availability of 211At: Near term steps towards global access	46
A kit formulation for the preparation of [89Zr]Zr(oxinate)4 for PET cell tracking: White blood cell labelling and comparison with [111In]In(oxinate)3	36
Overcoming nephrotoxicity in peptide receptor radionuclide therapy using [177Lu]Lu-DOTA-TATE for the treatment of neuroendocrine tumours	34
Gold nanoparticles meet medical radionuclides	31
Alpha emitting nuclides for targeted therapy	30
Current trends in the use of O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) in neurooncology	30
The development of 11C-carbonylation chemistry: A systematic view	27
Recent advancements in 18F-labeled PSMA targeting PET radiopharmaceuticals	25
Neutron-activated theranostic radionuclides for nuclear medicine	25
Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb	22
Renal brush border strategy: A developing procedure to reduce renal radioactivity levels of radiolabeled polypeptides	21
Expanding PET-applications in life sciences with positron-emitters beyond fluorine-18	20
The impact of barium isotopes in radiopharmacy and nuclear medicine – From past to presence	20
Auger: The future of precision medicine	18
18F-labelled BODIPY dye as a dual imaging agent: Radiofluorination and applications in PET and optical imaging	18
Site-specific radioiodination of an anti-HER2 single domain antibody fragment with a residualizing prosthetic agent	17
In vivo tracking of [89Zr]Zr-labeled engineered extracellular vesicles by PET reveals organ-specific biodistribution based upon the route of administration	16
Demystifying solid targets: Simple and rapid distribution-scale production of [68Ga]GaCl3 and [68Ga]Ga-PSMA-11	16
From the target cell theory to a more integrated view of radiobiology in Targeted radionuclide therapy: The Montpellier group's experience	16
Review: PET imaging with macro- and middle-sized molecular probes	15

Synthesis and preliminary evaluation of 211At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer	15
Combination radionuclide therapy: A new paradigm	14
Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1	14
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer	14
Synthesis and evaluation of [18F]FP-Lys-GE11 as a new radiolabeled peptide probe for epidermal growth factor receptor (EGFR) imaging	13
[89Zr]Zr-DBN labeled cardiopoietic stem cells proficient for heart failure	13
Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of β-amyloid in the brain	13
[68Ga]/[90Y]FAPI-46: Automated production and analytical validation of a theranostic pair	13
BLZ945 derivatives for PET imaging of colony stimulating factor-1 receptors in the brain	13
Radiolanthanum: Promising theranostic radionuclides for PET, alpha, and Auger-Meitner therapy	12
Metabolic characteristics of [18F]fluoroboronotyrosine (FBY) PET in malignant brain tumors	12
Bismuth chelation for targeted alpha therapy: Current state of the art	12
Radioarsenic: A promising theragnostic candidate for nuclear medicine	12
Radiolabeling with [11C]HCN for Positron emission tomography	12
Target manufacturing by Spark Plasma Sintering for efficient 89Zr production	12
A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models	12
Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET	11
Targeted Auger electron-emitter therapy: Radiochemical approaches for thallium-201 radiopharmaceuticals	11
New method for production of 155Tb via 155Dy by irradiation of natGd by medium energy alpha particles	11
Molecular imaging of microbiota-gut-brain axis: searching for the right targeted probe for the right target and disease	11
Kinetic isotope effects and synthetic strategies for deuterated carbon-11 and fluorine-18 labelled PET radiopharmaceuticals	11
45Ti targeted tracers for PET imaging of PSMA	10
Evaluation of 134Ce as a PET imaging surrogate for antibody drug conjugates incorporating 225Ac	10
A decade of ubiquicidin development for PET imaging of infection: A systematic review	10
Radiation dosimetry and efficacy of an 89Zr/225Ac-labeled humanized anti-MUC5AC antibody	10
Preclinical evaluation of new α-radionuclide therapy targeting LAT1: 2-[211At]astato-α-methyl-L-phenylalanine in tumor-bearing model	10
The emerging role of artificial intelligence and digital twins in pre-clinical molecular imaging	9
Molecular imaging and treatment of PSMA-positive prostate cancer with 99mTc radiolabeled aptamer-siRNA chimeras	9
AAZTA5-squaramide ester competing with DOTA-, DTPA- and CHX-A″-DTPA-analogues: Promising tool for 177Lu-labeling of monoclonal antibodies under mild conditions	9
A novel anti-angiogenic radio/photo sensitizer for prostate cancer imaging and therapy: 89Zr-Pt@TiO2-SPHINX, synthesis and in vitro evaluation	9
High-yield cyclotron production of 203Pb using a sealed 205Tl solid target	9
Radiolabeling of a polypeptide polymer for intratumoral delivery of alpha-particle emitter, 225Ac, and beta-particle emitter, 177Lu	9
Effects of 18F-fluorinated neopentyl glycol side-chain on the biological characteristics of stilbene amyloid-β PET ligands	9
Non-invasive immunoPET imaging of PD-L1 using anti-PD-L1-B11 in breast cancer and melanoma tumor model	8
Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers	8
Discovery of a CSF-1R inhibitor and PET tracer for imaging of microglia and macrophages in the brain	8
PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data	8
68Ga-labeled PET tracers for targeting tumor hypoxia: Role of bifunctional chelators on pharmacokinetics	8
Brown adipose tissue imaging using the TSPO tracer [18F]fluoromethyl-PBR28-d2: A comparison with [18F]FDG	8
Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic	8
Radiolabeling of PSMA-617 with 89Zr: A novel use of DMSO to improve radiochemical yield and preliminary small-animal PET results	8
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy	7
Tracer development for PET imaging of proteinopathies	7
68Ga-labelled-exendin-4: New GLP1R targeting agents for imaging pancreatic β-cell and insulinoma	7
[131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma	7
[99mTc]Tc-iPSMA SPECT brain imaging as a potential specific diagnosis of metastatic brain tumors and high-grade gliomas	7
A radioiodinated rucaparib analogue as an Auger electron emitter for cancer therapy	7
[68Ga]Ga-iPSMA-Lys3-Bombesin: Biokinetics, dosimetry and first patient PET/CT imaging	7
Development and in vitro evaluation of new bifunctional 89Zr-chelators based on the 6-amino-1,4-diazepane scaffold for immuno-PET applications	7
Synthesis and evaluation of 2-pyrrolopyridinylquinoline derivatives as selective tau PET tracers for the diagnosis of Alzheimer's disease	7

A reverse 230U/226Th radionuclide generator for targeted alpha therapy applications	7
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo	7
Labeling single domain antibody fragments with 18F using a novel residualizing prosthetic agent — N-succinimidyl 3-(1-(2-(2-(2-(2-[18F]fluoroethoxy)ethoxy)ethoxy)ethyl)-1H-1,2,3-triazol-4-yl)-5-(guani	6
Improved separation scheme for 44Sc produced by irradiation of natCa targets with 12.8 MeV protons	6
Cell death PET/CT imaging of rat hepatic fibrosis with 18F-labeled small molecule tracer	6
Investigating intrinsic radiosensitivity biomarkers to peptide receptor radionuclide therapy with [177Lu]Lu-DOTATATE in a panel of cancer cell lines	6
Passive and receptor mediated brain delivery of an anti-GFAP nanobody	6
A preliminary biodistribution study of [99mTc]sodium pertechnetate prepared from an electron linear accelerator and activated carbon-based 99mTc generator	6
Methods and techniques for in vitro subcellular localization of radiopharmaceuticals and radionuclides	6
Evaluation of the α-synuclein PET radiotracer (d3)-[11C]MODAG-001 in pigs	6
Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713	6
[11C]phosgene: Synthesis and application for development of PET radiotracers	6
Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold	6
Synthesis and evaluation of 68Ga-labeled imidazothiadiazole sulfonamide derivatives for PET imaging of carbonic anhydrase-IX	6
Production, isolation, and shipment of clinically relevant quantities of astatine-211: A simple and efficient approach to increasing supply	5
Validation of the plasmid study to relate DNA damaging effects of radionuclides to those from external beam radiotherapy	5
Development and validation of the HPLC method for quality control of radiolabelled DOTA-TATE and DOTA-TOC preparations	5
Dose estimation after a mixed field exposure: Radium-223 and intensity modulated radiotherapy	5
Preclinical evaluation of [11C]GW457427 as a tracer for neutrophil elastase	5
Development of a PET radioligand selective for cerebral amyloid angiopathy	5
18F-Chemistry in HPLC vials - a microliter scale radiofluorination approach	5
Synthesis and ex vivo biodistribution of two 68Ga-labeled tetrazine tracers: Comparison of pharmacokinetics	5
HRD1 attenuates the high uptake of [18F]FDG in hepatocellular carcinoma PET imaging	5
Applying radiobiology to clinical molecular radiotherapy	4
Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1	4
In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain	4
Kit-based preparation of [68Ga]Ga-P16-093 (PSMA-093) using different commercial 68Ge/68Ga generators	4
Theranostic cobalt-55/58m for neurotensin receptor-mediated radiotherapy in vivo: A pilot study with dosimetry	4
Synthesis, radiolabeling, and preclinical in vivo evaluation of 68Ga-radiolabelled nanodiamonds	4
News ways of understanding the complex biology of diabetes using PET	4
Novel application of [18F]DPA714 for visualizing the pulmonary inflammation process of SARS-CoV-2-infection in rhesus monkeys (Macaca mulatta)	4
Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer	4
Microwave-assisted synthesis of [52Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling	4
An original radio-biomimetic approach to synthesize radiometabolites for PET imaging	4
Evaluation and selection of a lead diabody for interferon-γ PET imaging	4
Radiosynthesis and initial preclinical evaluation of [11C]AZD1283 as a potential P2Y12R PET radiotracer	4
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, 99mTc and 186Re metal centers: Radiochemistry and in vitro evaluation	4
Use of radiolabeled hyaluronic acid for preclinical assessment of inflammatory injury and acute respiratory distress syndrome	3
Identification and quantitative structure–activity relationship assessment of trace chemical impurities contained in the therapeutic formulation of [64Cu]Cu-ATSM	3
Towards the development of a targeted albumin-binding radioligand: Synthesis, radiolabelling and preliminary in vivo studies	3
First microvolume metal-mediated synthesis of [18F]FDOPA in a microreactor	3
Radiosynthesis and evaluation of N5-(2-18F-fluoropropanyl) ornithine as a potential agent for tumor PET imaging	3
Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model	3
An alternative radiochemical separation strategy for isolation of Ac and Ra isotopes from high energy proton irradiated thorium targets for further application in Targeted Alpha Therapy (TAT)	3
Auger electron therapy of glioblastoma using [125I]5-iodo-2′-deoxyuridine and concomitant chemotherapy – Evaluation of a potential treatment strategy	3
Reduction of tumor hypoxia by anti-PD-1 therapy assessed using pimonidazole and [18F]FMISO	3
Characterization of actinide resin for separation of 51,52gMn from bulk target material	3
Development and biodistribution studies of 77As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [77As]As-trithiol-Ser-Ser-RM2 vs. [77As]As-trithiol-Glu-Ser-RM2	3
Imaging of microglia in post-stroke inflammation	3
Development of novel 67/68Ga-labeled pyridyl benzofuran derivatives as islet amyloid imaging probes	3
Comparison of analytical methods for antibody conjugates with application in nuclear imaging – Report from the trenches	3
Influence of short PEG linkers on biodistribution of 225Ac-Macropa-YS5, an immunoconjugate for treating CD46 expressing cancer	3
A receptor-binding radiopharmaceutical for imaging of traumatic brain injury in a rodent model: [99mTc]Tc-tilmanocept	3
In vivo validation of 68Ga-labeled AMD3100 conjugates for PET imaging of CXCR4	3
Integrin αvβ3 and EGFR dual-targeted [64Cu]Cu-NOTA-RGD-GE11 heterodimer for PET imaging in pancreatic cancer mouse model	3
Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist	3
Radiopharmacy in Africa: current status and future directions	3
Novel radiogallium-labeled pyridyl benzofuran derivative for detection of amylin aggregates in pancreas	3
p-NCS-Bn-NODAGA as a bifunctional chelator for radiolabeling with the 186Re/99mTc-tricarbonyl core: Radiochemistry with model complexes and a GRPR-targeting peptide	3
Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone	2
Feasibility studies of radioiodinated pyridyl benzofuran derivatives as potential SPECT imaging agents for prion deposits in the brain	2
Choosing the right molar activity of an 122I-labeled irreversible inhibitor of transglutaminase 2 for quantitative expression profiling in tissues	2
Automated production of [11C]butyrate for keto body PET imaging	2
Perspectives on nuclear chemistry, radiochemistry, PET/SPECT imaging and radiotherapy	2
Multimodal radiobioconjugate - Trastuzumab-PEG-[198Au]AuNPs-PEG-DOX for targeted radionuclide therapy of HER2-positive cancers	2
Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO	2
Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation	2
Astatine-211-labeled aza-vesamicol derivatives as sigma receptor ligands for targeted alpha therapy	2
Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides	2
Evaluation of N-(6-[18F]Fluoropyridin-3-yl)glycine PET renography to detect renal function progression in a rat model of diabetic nephropathy	2
The synthesis and bioevaluation of a novel and brain penetrable PARP1 tracer [18F]Pamiparib in rodents and nonhuman primates	2
Rapid detection of SARS-CoV-2 using a radiolabeled antibody	2
Cyclotron production of the 64Cu theranostic radiometal using a novel 68Zn sealed solid target	2
Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2	2
Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[18F]fluoro-phenylalanine: A comparative PET/CT study with L-isomer in healthy human volunteers	2
Synthesis and evaluation of [18F]cinacalcet for the imaging of parathyroid hyperplasia	2
First-in-human evaluation of [99mTc]Tc-(HE)3-G3, a novel DARPin-based agent for imaging of HER2 expression in breast cancer	2
Know thy tumour: Biomarkers to improve treatment of molecular radionuclide therapy	2
Synthesis and fluorine-18 radiolabeling of a phospholipid as a PET imaging agent for prostate cancer	2
A new in silico approach to revolutionize CNS PET tracer design and enhance translational success	2

Production of positron-emitting radionuclide yttrium-86 with a computer-aided design target for positron emission tomography	2
Evaluation of a novel hexadentate 1,2-hydroxypyridinone-based acyclic chelate, HOPO-O6-C4, for 43Sc/47Sc, 68Ga, and 45Ti radiopharmaceuticals	2
MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons	2
Replacing high-performance liquid chromatography (HPLC) with high-resolution thin layer chromatography (TLC) for rapid radiopharmaceutical analysis	2
Development of 123I-labelled acrylamides as radiotracer candidates for transglutaminase 2	2
Uptake of nicotinic acetylcholine receptor imaging agent is reduced in the pro-inflammatory macrophage	2
High yield lead-203 cyclotron production using a thallium-205 sealed solid target for diagnostic SPECT imaging	2
Cell membrane localization of terbium-161 using peptide receptor antagonists: can we profit from Auger electron emission with non-internalizing targeting agents?	2
Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy	2
Laminated holmium-166-containing electrospun bandages for use against skin cancer	2
18F-labeling and initial in vivo evaluation of a Hitomi peptide for imaging tissue transglutaminase 2	2
The production of 161Tb and its introduction to the clinic through the Good Manufacturing Practice-compliant radiolabeling of [161Tb]Tb-DOTATOC	2
Evaluation of [47Sc]Sc-HOPO toward radioscandium based radiopharmaceuticals	2
Improved purification of cyclotron [68Ga]GaCl3 for the production of 68Ga radiopharmaceuticals	2
Synthesis and preclinical evaluation of two osimertinib isotopologues labeled with carbon-11 as PET tracers targeting the tyrosine kinase domain of the epidermal growth factor receptor	1
Automated production of [18F]AldoView: first translation of a sulfonium salt precursor to GMP	1
The effect of base strengths on the radiochemical yields of S[18F]FB synthesis	1
Preparation and labelling of red blood cells with [68Ga]Ga-oxine for PET/CT imaging of the human spleen	1
Synthesis and preclinical evaluation of PD-L1 PET tracer [18F]FDHPA in mice	1
Synthesis of [18F] fluorine-labeled K-2 derivatives as radiotracers for AMPA receptors	1
Status of radiobiology in molecular radionuclide therapy – Hope for the future	1
223Ra-radiolabeling: predicting stability using molecular modelling	1
A brief history of the Society of Radiopharmaceutical Sciences	1
Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nano	1
Novel O-[11C]-methylated derivatives of the neprilysin inhibitor sacubitril: Radiosynthesis, autoradiography and plasma stability evaluation	1
Evaluation of polyazamacrocycles functionalized with sulphur-containing pendant arms as potential chelators for theranostic silver-111	1
Evaluation of acute intravenous toxicity of HEPES: Is Good's buffer good and safe enough for clinical utilization in nuclear medicine?	1
Combined PD-L1–targeted radionuclide therapy with immunotherapy in two models of colorectal cancer	1
Bispecific antibody-based radiopharmaceutical towards phosphorylated TDP-43	1
Preclinical evaluation of [225Ac]Ac-crown-TATE – An alpha-emitting radiopharmaceutical for neuroendocrine tumors	1
18F-Functionalization of sulfur heteroatom frameworks via isotopic exchange in hydrous organic media	1
Pre-clinical evaluation of immunoPET imaging using agonist CD40 monoclonal antibody in pancreatic tumor-bearing mice	1
[18F]FDG and [11C]PK11195 PET imaging in the evaluation of brown adipose tissue - effects of cold and pharmacological stimuli and their association with crotamine intake in a male mouse model	1
Development of freeze-dried kits for one-step expeditious formulation of [68Ga]Ga-NODAGA-JR11	1
Noninvasively visualize the expression of LAPTM4B protein using a novel 18F-labeled peptide PET probe in hepatocellular carcinoma	1
Automated radiosynthesis and preclinical in vivo evaluation of [18F]Fluoroethylpuromycin as a potential radiotracer for imaging protein synthesis with PET	1
Chelation chemistry of manganese-52 for PET imaging applications	1
Development of a CCR2 targeted 18F-labeled radiotracer for atherosclerosis imaging with PET	1
Simple and rapid automated synthesis of L-[11C]glutamine	1
Biodistribution study of 211Pb progeny released from intravenously applied 223Ra labelled TiO2 nanoparticles in a mouse model	1
HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [99mTc]Tc-HMPAO-labelling procedure: A quality control study	1
Biological evaluation of a novel stable peptide PET molecular probe [18F]AlF-NOTA-DVAP targeting to tumor cell surface GRP78	1
Biologicals as theranostic vehicles in paediatric oncology	1
Fully automated dual-run manufacturing of [11C]PIB on FASTlab	1
[99mTc]Tc-HYNIC-RM2: A potential SPECT probe targeting GRPR expression in prostate cancers	1
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases	1
Production of 117mSn using Sb alloy targetry	1
Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes	1
One batch multiple clinical doses production of [18F]FET with an home-built automated multipurpose [18F]-radiosynthesis module	1
Synthesis/radiosynthesis and evaluation of three 18F radiotracers for imaging of sphingosine-1-phosphate receptor 1	1
Evaluation of targeting αVβ3 in breast cancers using RGD peptide-based agents	1
Development of alpha particle emitting radionuclide therapy according to GMP guidelines for treatment of mCRPC	1
Modification of a commercial radiochemistry module for facile cGMP production of [18F]FET and [18F]FSPG	1
Development and exploration of bifunctional chelating ligands for mercury-197m/g	1
Fast, efficient, one-step purification of cyclotron produced lanthanum-135 using HDEHP-based resin and dilute hydrochloric acid	1
Radiochemical formulation of 177Lu-DOTA-trastuzumab: using low specific activity 177LuCl3	1
Imaging of cell death in malignancy: Targeting pathways or phenotypes?	1
Mini-review: Antibody-PET of receptor tyrosine kinase interplay and heterogeneity	1
Evaluation of the high affinity [18F]fluoropyridine-candesartan in rats for PET imaging of renal AT1 receptors	1
Assessment of drug transporters involved in the urinary secretion of [99mTc]dimercaptosuccinic acid	1
Au@Pt core-shell nanoparticle bioconjugates for Auger electron radiotherapy – preliminary studies	1
A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation	1
In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies	1
Automated production of [68Ga]Ga-DOTA-exendin-4 via fractionated radionuclide generator elution on a cassette based synthesis module	1
Radiolabeling and biological evaluation of functionalized spherical nucleic acids	1
N-(4-[18F]fluorobenzyl)cholylglycine, a potential tracer for positron emission tomography of enterohepatic circulation and drug-induced inhibition of ileal bile acid transport. A proof-of-concept PET/	1
Copper-61 from liquid targets: optimized purification for GMP labelling	1
Evaluation of affinity matured Affibody molecules for imaging of the immune checkpoint protein B7-H3	1
Evaluation of neuroinflammatory radiotracers in chronic traumatic encephalopathy	1
Solid phase radiosynthesis of an olaparib derivative using 4-[18F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expression	1
Co-production of 155Tb and 152Tb irradiating 155Gd / 151Eu tandem target with a medium energy α-particle beam	1
DOTA derivatives with sulfur containing side chains as an attempt to thwart the biological instability of copper labelled radiotracers	1
Development of novel sulfur-rich ligands for incorporation into mercury-197m/g radiopharmaceuticals	1
Comparison of the synthesis and biological properties of no-carrier-added and carrier-added 4-borono-2-[18F]fluorophenylalanine ([18F]FBPA)	1
Synthesis and biological evaluation of a novel radioligand [11C] BIO-1790735 for detection of O-GlcNAcase (OGA) enzyme activity	1
Evaluation of [11C]HSP990 as a PET probe for in vivo visualisation of heat shock protein 90 in tumours	1
Preclinical evaluation of MC1R targeting theranostic pair [155Tb]Tb-crown-αMSH and [161Tb]Tb-crown-αMSH	1
Formulation and evaluation of human clinical doses of 177Lu-labeled bisphosphonate amide of DOTA using lyophilized kits	1
Synthesis and preclinical evaluation of [11C]LR111 and [18F]EW-7197 as PET tracers of the activin-receptor like kinase-5	1
Cyclotron production of 103Pd using a liquid target	1
Development and preclinical evaluation of PSMA-targeting trimers based on the NOTI chelating platform	1
Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine	1
Rhenium and technetium complexes in extremely low oxidation states	1
Imaging Lung Tumor Metastasis with 89Zr-DFO-Crizanlizumab Targeting P-selectin	1
Radiosynthesis and evaluation of 18F-labeled dopamine D4-receptor ligands	1
Radiosynthesis of 18F labelled D-amino acid tracers and their use for bacteria imaging	1
Evaluation of F-537-Tetrazine in a model for brain pretargeting imaging. Comparison to N-(3-[18F] fluoro-5-(1,2,4,5-tetrazin-3-yl)benzyl)propan-1-amine	1
Harnessing the theranostic potential of lead radioisotopes with sulphur-containing macrocycles	1
Transition-metal-free reductive coupling of an 18F-labeled nitro-arene with boronic acids as a potential access to 18F-labeled fenamates	1
Retraction notice to “Radiosynthesis and biological evaluation of fluorine-18 labeled N-acetylgalactosamine derivative [18F]FPGalNAc for PET imaging of asialoglycoprotein receptor-positive tumors”. [N	0
Targeted radioimmunotherapy of PD1+ cells for the treatment of multiple sclerosis	0
Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen	0
Outside Back Cover - Graphical abstract TOC/TOC in double column/Cover image legend if applicable, Bar code, Abstracting and Indexing information	0
Editorial Board	0
Production, purification and formulation of nanoradiopharmaceutical with 211At: An emerging candidate for targeted alpha therapy	0